Logo Image
News
OncClubAll Oncology NewsClinical Trials in Focus
Media
InsightsMedNews WeekOncChatsOncLive News Network®OncLive TVPeer ExchangePodcastsRapid ReadoutsShorts
Conferences
Conference CoverageConference Listing
Events
Giants of Cancer CareCME/CEScientific InterchangesState of the Science Summit / IPCNational Fellows ForumWebinars
More
Partners
Publications
All PublicationsSupplements
Resources
Consensus ViewpointsOncLive AppInteractive ToolsSponsored
Biomarker Consortium

Subscribe

  • News
  • Media
  • Conferences
  • Events
  • Partners
  • Publications
  • Resources
  • Biomarker Consortium
  • Subscribe
  • AI for Oncology
  • Biosimilars
  • Brain Cancer
  • Breast Cancer
    • HER2+ Breast Cancer
  • CAR T-Cell Therapy
  • Disparities in Cancer Care
  • Gastrointestinal Cancer
    • Pancreatic Cancer
    • Hepatocellular Carcinoma
    • Gastric Cancer
    • Colorectal Cancer
  • Genitourinary Cancers
    • Urothelial Cancer
    • Prostate Cancer
  • Global Oncology
  • Graft-vs-Host Disease
  • Gynecologic Oncology
    • Ovarian Cancer
  • Head & Neck Cancers
  • Hematologic Oncology
    • Chronic Lymphocytic Leukemia
    • Non-Hodgkin Lymphoma
    • Mantle Cell Lymphoma
    • Multiple Myeloma
    • Myeloproliferative Neoplasms
  • Immuno-Oncology
  • Lung Cancer
  • Melanoma & Skin Cancer
  • Oncology Business Management
  • Pediatric Oncology
  • Precision Medicine in Oncology®
  • Sarcomas
  • Supportive Care
Spotlight -
The OncLive Insider app is live!|
CME Opportunities
Advertisement

Evolving Treatment Paradigms for B-Cell Non-Hodgkin Lymphoma

EP. 1: Follicular Lymphoma; Triggers to Initiate Therapy

January 12th 2017

EP. 2: Follicular Lymphoma: Consolidation and Maintenance

January 12th 2017

EP. 3: Sequencing Therapies for Follicular Lymphoma

January 12th 2017

EP. 4: R2-CHOP for Relapsed Follicular Lymphoma

January 12th 2017

EP. 5: Emerging Therapies for Follicular Lymphoma

January 12th 2017

EP. 6: Chronic Lymphocytic Leukemia; Initiating Therapy

January 12th 2017

EP. 7: CLL Risk Stratification and Treatment Approach

January 12th 2017

EP. 8: The Role of Maintenance Therapy in CLL

January 12th 2017

EP. 9: Sequencing Therapies for Relapsed/Refractory CLL

January 12th 2017

EP. 10: Managing Ibrutinib Toxicity in CLL

January 12th 2017

EP. 11: Ibrutinib for CLL with Deletion 17p

January 12th 2017

EP. 12: CAR-T Cell Therapies in CLL

January 12th 2017

EP. 13: Risk-Based Therapy for DLBCL

January 12th 2017

EP. 14: Treating High-Grade Lymphoma

January 12th 2017

EP. 15: Maintenance Therapy for DLBCL

January 12th 2017

EP. 16: Relapsed/Refractory DLBCL

January 12th 2017

EP. 17: CAR-T Therapy for DLBCL

January 12th 2017

EP. 18: DLBCL: CAR-T as Curative Treatment/Bridge to Transplant

January 12th 2017

EP. 19: The Future of Treatment of B-Cell Lymphoma

January 12th 2017
Advertisement
Advertisement

Trending on OncLive

1

FDA Approves Gedatolisib Plus Fulvestrant ± Palbociclib for Hormone Receptor–Positive, HER2-Negative, Locally Advanced/Metastatic Breast Cancer

2

Access, Sequencing Considerations Remain Key Focal Points for CAR T-Cell Therapy in R/R Myeloma

3

Dr Jabbour on the Significance of the FDA Approval of Orally Disintegrating Nilotinib Tablets for CML

4

FDA Awards Traditional Approval to Selpercatinib for RET+ Advanced Solid Tumors

5

Dr Danilov on the Rationale and Design of DAYBreak CLL-201 Evaluating Bexobrutideg in R/R CLL

  • Advertise
  • About OncLive
  • Editorial Board
  • MJH Life Sciences brands
  • Contact Us
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo
Download on Apple
Download on Google Play

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us